Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most intractable malignancy, with an only 6% 5-year relative survival rate. The dismal therapeutic effect is attributed to the chemotherapy resistance and unique pathophysiology with abundant inflammatory cytokines and abnormal hyperplasia of ext...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yu, Zhou, Wenxi, Chen, Xinli, Wang, Qingbing, Li, Chao, Chen, Qinjun, Zhang, Yu, Lu, Yifei, Ding, Xiaoyi, Jiang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488356/
https://www.ncbi.nlm.nih.gov/pubmed/32963950
http://dx.doi.org/10.1016/j.apsb.2019.11.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488356/
https://www.ncbi.nlm.nih.gov/pubmed/32963950
http://dx.doi.org/10.1016/j.apsb.2019.11.013

Ejemplares similares